Calcium antagonists and cardiovascular events in patients with hypertension and diabetes

被引：21

作者：

Alderman, M ^{[1
]}

Madhavan, S ^{[1
]}

Cohen, H ^{[1
]}

机构：

[1] Yeshiva Univ Albert Einstein Coll Med, Dept Epidemiol & Social Med, Bronx, NY 10461 USA

来源：

LANCET | 1998年 / 351卷 / 9097期

关键词：

D O I：

10.1016/S0140-6736(05)78175-7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：216 / 217

页数：2

共 4 条

[1] Effect of long-acting and short-acting calcium antagonists on cardiovascular outcomes in hypertensive patients [J].

Alderman, MH ;

Cohen, H ;

Roque, R ;

Madhavan, S .

LANCET, 1997, 349 (9052) :594-598

[2] Final outcome results of the multicenter isradipine diuretic atherosclerosis study (MIDAS) - A randomized controlled trial [J].

Borhani, NO ;

Mercuri, M ;

Borhani, PA ;

Buckalew, VM ;

CanossaTerris, M ;

Carr, AA ;

Kappagoda, T ;

Rocco, MV ;

Schnaper, HW ;

Sowers, JR ;

Bond, MG .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (10) :785-791

[3] Isradipine, raised glycosylated haemoglobin, and risk of cardiovascular events [J].

Byington, RP ;

Craven, TE ;

Furberg, CD ;

Pahor, M .

LANCET, 1997, 350 (9084) :1075-1076

[4]

TATTI P, 1997, NOV 12 1997 AM HEART

← 1 →